Jover, E.; Matilla, L.; Garaikoetxea, M.; Fernández-Celis, A.; Muntendam, P.; Jaisser, F.; Rossignol, P.; López-Andrés, N.
Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein. Biomedicines 2021, 9, 639.
https://doi.org/10.3390/biomedicines9060639
AMA Style
Jover E, Matilla L, Garaikoetxea M, Fernández-Celis A, Muntendam P, Jaisser F, Rossignol P, López-Andrés N.
Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein. Biomedicines. 2021; 9(6):639.
https://doi.org/10.3390/biomedicines9060639
Chicago/Turabian Style
Jover, Eva, Lara Matilla, Mattie Garaikoetxea, Amaya Fernández-Celis, Pieter Muntendam, Frédéric Jaisser, Patrick Rossignol, and Natalia López-Andrés.
2021. "Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein" Biomedicines 9, no. 6: 639.
https://doi.org/10.3390/biomedicines9060639
APA Style
Jover, E., Matilla, L., Garaikoetxea, M., Fernández-Celis, A., Muntendam, P., Jaisser, F., Rossignol, P., & López-Andrés, N.
(2021). Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein. Biomedicines, 9(6), 639.
https://doi.org/10.3390/biomedicines9060639
